GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice.
Takashi NakamuraHitomi TanimotoMasayuki OkamotoMitsuaki TakeuchiYoshiharu TsubamotoHitoshi NodaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
SKL-14959 might direct lipids metabolism to catabolism by inhibition of plasma LPL activity, resulting in the suppression of weight gain on diets-induced obesity mice.